Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005227235
Thu, 01.06.2023
Biotest AG
PRESS RELEASE
Biotest presents gigantic artwork to visualize its sustainability initiatives
International Eco-Art artist creates large-scale mural to visualize company's sustainability efforts
Special paint with sophisticated technology creates air-purifying effect
With its GoFuture sustainability initiative, Biotest aims to grow in lin [ … ]
Thu, 01.06.2023
Biotest AG
PRESS RELEASE
Biotest presents gigantic artwork to visualize its sustainability initiatives
International Eco-Art artist creates large-scale mural to visualize company's sustainability efforts
Special paint with sophisticated technology creates air-purifying effect
With its GoFuture sustainability initiative, Biotest aims to grow in lin [ … ]
Tue, 09.05.2023
Biotest AG
PRESS RELEASE
Annual General Meeting of Biotest AG elects Raimon Grifols Roura to the Supervisory Board
Broad majority on all agenda items according to the proposals of the administration
Q1 report published
Dreieich, 9 May 2023. 96 shareholders and guests attended the Annual General Meeting of Biotest AG. A total of 78.15 perc [ … ]
Tue, 09.05.2023
Biotest AG
PRESS RELEASE
Annual General Meeting of Biotest AG elects Raimon Grifols Roura to the Supervisory Board
Broad majority on all agenda items according to the proposals of the administration
Q1 report published
Dreieich, 9 May 2023. 96 shareholders and guests attended the Annual General Meeting of Biotest AG. A total of 78.15 perc [ … ]
Thu, 04.05.2023
Biotest AG
PRESS RELEASE
Biotest’s Hyperimmunoglobulin Cytotect® CP receives five additional Marketing Authorisations in Europe
Approval of Biotest’s CMV-hyperimmunoglobulin in now 28 markets will secure future revenue growth
Biotest’s CMV-hyperimmunoglobulin is indicated for prophylaxis of clinical manifestations of cytomegalovirus (CMV) infections – a [ … ]
Thu, 04.05.2023
Biotest AG
PRESS RELEASE
Biotest’s Hyperimmunoglobulin Cytotect® CP receives five additional Marketing Authorisations in Europe
Approval of Biotest’s CMV-hyperimmunoglobulin in now 28 markets will secure future revenue growth
Biotest’s CMV-hyperimmunoglobulin is indicated for prophylaxis of clinical manifestations of cytomegalovirus (CMV) infections – a [ … ]
Tue, 25.04.2023
Biotest AG
PRESS RELEASE
Biotest AG opens 12th plasma collection centre in Hungary
36 plasma collection stations in Europe to secure the plasma supply in the long term
Dreieich, 25 April 2023. Biotest has officially opened the 12th plasma collection centre in Hungary in Budapest, after previously being granted an operating licence by the Hunga [ … ]
Tue, 25.04.2023
Biotest AG
PRESS RELEASE
Biotest AG opens 12th plasma collection centre in Hungary
36 plasma collection stations in Europe to secure the plasma supply in the long term
Dreieich, 25 April 2023. Biotest has officially opened the 12th plasma collection centre in Hungary in Budapest, after previously being granted an operating licence by the Hunga [ … ]
Thu, 20.04.2023
Biotest AG
PRESS RELEASE
Biotest AG opens 10th plasma collection centre in Germany
35 plasma collection centres in Europe to secure long term plasma supply
Dreieich, 20 April 2023. Biotest has officially opened the 10th plasma collection centre in Germany in Münster in Westphalia.
In future, plasma donors will be able to donate plasma six day [ … ]
Thu, 20.04.2023
Biotest AG
PRESS RELEASE
Biotest AG opens 10th plasma collection centre in Germany
35 plasma collection centres in Europe to secure long term plasma supply
Dreieich, 20 April 2023. Biotest has officially opened the 10th plasma collection centre in Germany in Münster in Westphalia.
In future, plasma donors will be able to donate plasma six day [ … ]